Company
Create Medicines
| Industry | developer of in vivo immune programming and mRNA-LNP cell therapies |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Create Medicines | Series B | 2026-05-14 |
Company
| Industry | developer of in vivo immune programming and mRNA-LNP cell therapies |
|---|
| Company | Round | Date |
|---|---|---|
| Create Medicines | Series B | 2026-05-14 |